Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heterochromatin | 4 | 2020 | 19 | 1.050 |
Why?
|
| STAT3 Transcription Factor | 3 | 2020 | 102 | 0.760 |
Why?
|
| Drosophila Proteins | 3 | 2020 | 188 | 0.700 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2020 | 65 | 0.670 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 11 | 0.670 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2020 | 61 | 0.620 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 241 | 0.560 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 495 | 0.520 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 95 | 0.510 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.440 |
Why?
|
| Phosphorylation | 6 | 2020 | 986 | 0.350 |
Why?
|
| Signal Transduction | 7 | 2020 | 2157 | 0.280 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 2676 | 0.280 |
Why?
|
| Drosophila | 2 | 2020 | 152 | 0.250 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 291 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 968 | 0.210 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 1019 | 0.210 |
Why?
|
| Cell Proliferation | 6 | 2020 | 1455 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 307 | 0.200 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2020 | 45 | 0.200 |
Why?
|
| Histones | 4 | 2020 | 197 | 0.200 |
Why?
|
| Mice, Nude | 2 | 2020 | 408 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 347 | 0.160 |
Why?
|
| Receptors, Notch | 1 | 2020 | 38 | 0.160 |
Why?
|
| Streptonigrin | 1 | 2020 | 1 | 0.160 |
Why?
|
| Models, Biological | 3 | 2019 | 712 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 51 | 0.160 |
Why?
|
| Methotrexate | 1 | 2019 | 22 | 0.150 |
Why?
|
| Mitosis | 1 | 2020 | 114 | 0.150 |
Why?
|
| Curcumin | 1 | 2020 | 118 | 0.150 |
Why?
|
| Testis | 1 | 2020 | 207 | 0.150 |
Why?
|
| S100 Proteins | 1 | 2019 | 13 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 62 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 436 | 0.140 |
Why?
|
| Animals | 7 | 2020 | 16992 | 0.140 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 193 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 95 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 137 | 0.130 |
Why?
|
| Chromatin | 1 | 2019 | 186 | 0.130 |
Why?
|
| Withanolides | 1 | 2017 | 10 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 189 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 34 | 0.130 |
Why?
|
| Telomerase | 1 | 2017 | 42 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 290 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 237 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 133 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 458 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 165 | 0.120 |
Why?
|
| Female | 4 | 2020 | 24698 | 0.120 |
Why?
|
| Humans | 12 | 2021 | 43102 | 0.120 |
Why?
|
| Neoplasms | 3 | 2019 | 1377 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 384 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 704 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1070 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2017 | 358 | 0.110 |
Why?
|
| Mice | 4 | 2020 | 6644 | 0.110 |
Why?
|
| Ecdysteroids | 1 | 2013 | 2 | 0.100 |
Why?
|
| Histone Demethylases | 1 | 2013 | 8 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 49 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 1472 | 0.100 |
Why?
|
| Hela Cells | 3 | 2020 | 376 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 223 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 223 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2019 | 74 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1723 | 0.070 |
Why?
|
| Animals, Genetically Modified | 2 | 2019 | 100 | 0.060 |
Why?
|
| Drug Resistance, Multiple | 1 | 2006 | 28 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2006 | 52 | 0.060 |
Why?
|
| Copper | 1 | 2006 | 134 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2020 | 383 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 592 | 0.050 |
Why?
|
| Male | 2 | 2020 | 23409 | 0.050 |
Why?
|
| Sirolimus | 1 | 2020 | 70 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 174 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 99 | 0.040 |
Why?
|
| Janus Kinases | 1 | 2019 | 23 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2019 | 37 | 0.040 |
Why?
|
| Pigmentation | 1 | 2019 | 28 | 0.040 |
Why?
|
| Color | 1 | 2019 | 38 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 70 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 74 | 0.040 |
Why?
|
| Eye | 1 | 2019 | 77 | 0.040 |
Why?
|
| Base Sequence | 1 | 2020 | 983 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 299 | 0.040 |
Why?
|
| Apoptosis | 1 | 2006 | 1568 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 667 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 509 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 587 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2017 | 60 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 127 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 430 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 386 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 883 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 518 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2019 | 735 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 17 | 0.030 |
Why?
|
| Homozygote | 1 | 2013 | 77 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 53 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2013 | 38 | 0.030 |
Why?
|
| Methylation | 1 | 2013 | 119 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2013 | 103 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 456 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 526 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 780 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1082 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1177 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 129 | 0.020 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 2006 | 20 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2006 | 74 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 204 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2006 | 97 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 247 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 678 | 0.010 |
Why?
|